> Details

Lode, Holger N.; Valteau-Couanet, Dominique; Troschke-Meurer, Sascha; Manzitti, Carla; Gray, Juliet; Castel, Victoria; Yaniv, Isaac; Loibner, Hans; Siebert, Nikolai; Glogova, Evgenia; Poetschger, Ulrike; Ladenstein, Ruth

Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma
  • Contributor: Lode, Holger N.; Valteau-Couanet, Dominique; Troschke-Meurer, Sascha; Manzitti, Carla; Gray, Juliet; Castel, Victoria; Yaniv, Isaac; Loibner, Hans; Siebert, Nikolai; Glogova, Evgenia; Poetschger, Ulrike; Ladenstein, Ruth
  • imprint: American Society of Clinical Oncology (ASCO), 2016
  • Published in: Journal of Clinical Oncology
  • Language: English
  • DOI: 10.1200/jco.2016.34.15_suppl.10562
  • ISSN: 1527-7755; 0732-183X
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access